X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (412) 412
Book / eBook (155) 155
Book Chapter (32) 32
Publication (31) 31
Book Review (15) 15
Conference Proceeding (3) 3
Dissertation (3) 3
Newsletter (3) 3
Newspaper Article (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (257) 257
index medicus (230) 230
oncology (145) 145
chemotherapy (129) 129
cancer (111) 111
hematology (101) 101
male (100) 100
female (93) 93
lymphomas (90) 90
rituximab (87) 87
medicine & public health (82) 82
therapy (78) 78
central nervous system (73) 73
non-hodgkins-lymphoma (71) 71
primary cns lymphoma (71) 71
middle aged (69) 69
clinical neurology (68) 68
methotrexate (66) 66
adult (65) 65
care and treatment (65) 65
aged (58) 58
diagnosis (57) 57
neurology (55) 55
diseases (54) 54
high-dose methotrexate (52) 52
transplantation (51) 51
treatment outcome (51) 51
central-nervous-system (48) 48
drug therapy (48) 48
central nervous system neoplasms - therapy (46) 46
lymphoma (44) 44
electronic books (43) 43
animals (42) 42
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
prognosis (42) 42
radiotherapy (42) 42
medicine (40) 40
treatment (39) 39
tumors (38) 38
pediatrics (37) 37
b-cell lymphoma (36) 36
drugs (36) 36
health aspects (36) 36
neurosciences (35) 35
research (35) 35
child (34) 34
disease (34) 34
lymphoma - therapy (34) 34
medical (34) 34
nervous system (34) 34
patients (33) 33
whole-brain radiotherapy (33) 33
immunology (32) 32
immunotherapy (32) 32
cerebrospinal-fluid (31) 31
nursing (31) 31
central nervous system neoplasms - diagnosis (30) 30
central nervous system neoplasms - drug therapy (30) 30
review (30) 30
internal medicine (29) 29
pharmacology (29) 29
retrospective studies (29) 29
risk factors (29) 29
stem cells (29) 29
central nervous system neoplasms - pathology (28) 28
stem-cell transplantation (28) 28
adolescent (27) 27
analysis (27) 27
combined modality therapy (27) 27
surgery (27) 27
handbooks, manuals, etc (26) 26
neoplasms (26) 26
pharmaceutical preparations (26) 26
methods (25) 25
methotrexate - administration & dosage (25) 25
pharmacology & pharmacy (25) 25
phase-ii (25) 25
antineoplastic agents - therapeutic use (24) 24
brain (24) 24
central nervous system neoplasms - mortality (24) 24
children (24) 24
young adult (24) 24
antineoplastic agents (23) 23
handbooks (23) 23
hematology, oncology and palliative medicine (23) 23
injections, spinal (23) 23
recurrence (23) 23
leukemia (22) 22
development and progression (21) 21
recurrent primary cns (21) 21
survival (21) 21
acute lymphoblastic-leukemia (20) 20
antibodies (20) 20
antibodies, monoclonal, murine-derived (20) 20
antineoplastic agents - administration & dosage (20) 20
lymphoma - pathology (20) 20
neurosurgery (20) 20
pathology (20) 20
antibodies, monoclonal - therapeutic use (19) 19
antibodies, monoclonal, murine-derived - administration & dosage (19) 19
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (27) 27
St. Michael's Hospital - Stacks (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
Scarborough Hospital - Birchmount (11) 11
Scarborough Hospital - General (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Lakeridge Health Sciences - Oshawa (8) 8
Humber River Regional Hospital - Church Stacks (7) 7
Markham Stouffville Hospital - Stacks (6) 6
Toronto East General Hospital - Stacks (6) 6
Dentistry (Harry R Abbott) - Stacks (5) 5
Providence Healthcare - Reference (5) 5
Gerstein Science - Circulation Desk (4) 4
Scarborough Hospital - Hospital Department (4) 4
St. Michael's Hospital - Circulation Desk (4) 4
Credit Valley Hospital - Reference (3) 3
Credit Valley Hospital - Stacks (3) 3
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (3) 3
Gerstein Science - Reference (3) 3
Holland Bloorview Kids Rehabilitation - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (3) 3
Online Resources - Online (3) 3
Trillium Health Centre - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Women's College Hospital - Stacks (3) 3
Providence Healthcare - Stacks (2) 2
St Josephs Health Centre - Reference (2) 2
St Josephs Health Centre - Stacks (2) 2
Stacks (2) 2
Sunnybrook Health Sciences Centre - Online (2) 2
Toronto East General Hospital - Online (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Reference (2) 2
Baycrest Hospital - Course Reserves (1) 1
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Special Collections (1) 1
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Dentistry (Harry R Abbott) - May be requested (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Pharmacy (1) 1
Holland Bloorview Kids Rehabilitation - Reference (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Humber River Regional Hospital - Departmental Stacks (1) 1
Humber River Regional Hospital - Finch Reference (1) 1
Lakeridge Health Sciences - Online (1) 1
Markham Stouffville Hospital - Storage (1) 1
Mt Sinai Hospital - Pathology (1) 1
Mt Sinai Hospital - Stacks (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Oshawa (1) 1
Pharmacy (1) 1
Providence Healthcare - Reserve desk (1) 1
Robarts - Reference (1) 1
Scarborough Hospital - Grace (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Pharmacy (1) 1
Women's College Hospital - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (600) 600
Spanish (8) 8
Czech (5) 5
Arabic (3) 3
Chinese (2) 2
Portuguese (2) 2
French (1) 1
Japanese (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Hematological Oncology, ISSN 0278-0232, 09/2013, Volume 31, Issue 3, pp. 143 - 150
Despite a high proportion of patients with primary CNS lymphoma (PCNSL) experiences failure after/during first‐line treatment, a few studies focused on salvage... 
ifosfamide | etoposide | primary CNS lymphoma | rituximab | autologous stem cell transplantation | Primary CNS lymphoma | Etoposide | Rituximab | Ifosfamide | Autologous stem cell transplantation | 1ST-LINE TREATMENT | IMMUNOCHEMOTHERAPY | INTRAOCULAR LYMPHOMA | PHASE-II | WHOLE-BRAIN RADIOTHERAPY | THERAPY | RESCUE | ONCOLOGY | RECURRENT PRIMARY CNS | CENTRAL-NERVOUS-SYSTEM | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Cranial Nerve Neoplasms - radiotherapy | Recurrence | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Drug Evaluation | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Central Nervous System Neoplasms - surgery | Cranial Nerve Neoplasms - drug therapy | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Cranial Nerve Neoplasms - surgery | Eye Neoplasms - surgery | Central Nervous System Neoplasms - radiotherapy | Eye Neoplasms - drug therapy | Female | Retrospective Studies | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Drug Administration Schedule | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cranial Irradiation | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Remission Induction | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Methotrexate - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Central Nervous System Neoplasms - drug therapy | Peripheral Blood Stem Cell Transplantation | Eye Neoplasms - radiotherapy | Care and treatment | Relapse | Chemotherapy | Lymphomas | Dosage and administration | Methotrexate | Diseases | Cancer
Journal Article
Leukemia, ISSN 0887-6924, 2017, Volume 31, Issue 12, pp. 2623 - 2629
To investigate safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (HCT-ASCT) in relapsed/refractory (r/r) primary... 
1ST-LINE TREATMENT | INTENSIVE CHEMOTHERAPY | ONCOLOGY | RECURRENT PRIMARY CNS | CLINICAL-TRIALS | PHASE-II | INTRAOCULAR LYMPHOMA | SALVAGE THERAPY | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | HEMATOLOGY | TRANSPLANTATION | Recurrence | Brain - diagnostic imaging | Prospective Studies | Lymphoma - diagnostic imaging | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Lymphoma - mortality | Lymphoma - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma - pathology | Central Nervous System Neoplasms - therapy | Treatment Outcome | Combined Modality Therapy | Retreatment | Central Nervous System Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Brain - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Chemotherapy | Care and treatment | Patient outcomes | Nervous system cancer | Stem cells | Development and progression | Lymphomas | Transplantation | Methods | Cancer | Brain | Autografts | Central nervous system | Stem cell transplantation | Rituximab | Radiation therapy | Patients | Survival | Lymphoma | Cytarabine | Salvage | Comparative studies | Remission | Methotrexate
Journal Article
Pediatric Transplantation, ISSN 1397-3142, 09/2012, Volume 16, Issue 6, pp. E201 - E209
Twombley K, Pokala H, Ardura MI, Harker‐Murray P, Johnson‐Welch SF, Weinberg A, Seikaly M. Intraventricular rituximab and systemic chemotherapy for treatment... 
post‐transplant lymphoproliferative | Epstein–Barr virus | pediatric kidney transplant | rituximab | post‐transplant lymphoproliferative disorder | Epstein-Barr virus | post-transplant lymphoproliferative disorder | post-transplant lymphoproliferative | PRIMARY CNS LYMPHOMA | RISK-FACTORS | PERIPHERAL-BLOOD | CEREBROSPINAL-FLUID | VIRAL LOAD CARRIAGE | TRANSPLANTATION | RECURRENT | NON-HODGKIN-LYMPHOMA | PTLD | PEDIATRICS | RADIOTHERAPY | EPSTEIN-BARR-VIRUS | Prognosis | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Kidney Transplantation - methods | Fatal Outcome | Adult | Postoperative Complications | Seizures | B-Lymphocytes - cytology | Dexamethasone - administration & dosage | Immunologic Factors - administration & dosage | Rituximab | Treatment Outcome | Epstein-Barr Virus Infections - drug therapy | Magnetic Resonance Imaging | Drug Therapy, Combination - methods | Adolescent | Central Nervous System Diseases - drug therapy | Epstein-Barr Virus Infections - complications | Lymphoproliferative Disorders - drug therapy | Methotrexate - administration & dosage | Herpesvirus 4, Human - metabolism | Infusions, Intraventricular | Kidney Transplantation - adverse effects | Care and treatment | Chemotherapy | Dexamethasone | Kidneys | Central nervous system | Transplantation | Children | Methotrexate | Health aspects | Cancer | Case reports
Journal Article
Hematological Oncology, ISSN 0278-0232, 12/2017, Volume 35, Issue 4, pp. 497 - 503
The prognosis of central nervous system (CNS) relapse of systemic non‐Hodgkin lymphoma is poor with 1‐year survival historically at 0% to 20%. Aiming to... 
clinical trial | treatment | methotrexate | secondary CNS lymphoma | rituximab | transplantation | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Transplantation, Autologous - methods | Lymphoma, Non-Hodgkin - pathology | Young Adult | Rituximab - therapeutic use | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Lymphoma, Non-Hodgkin - mortality | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Lymphoma, Non-Hodgkin - drug therapy | PRIMARY CNS LYMPHOMA | RESPONSE CRITERIA | INTRAOCULAR LYMPHOMA | CHEMOTHERAPY PLUS RITUXIMAB | STUDY-GROUP DSHNHL | ONCOLOGY | NON-HODGKINS-LYMPHOMA | AGGRESSIVE LYMPHOMA | MABTHERA INTERNATIONAL TRIAL | MARROW-TRANSPLANTATION | HEMATOLOGY | ELDERLY-PATIENTS | Clinical trials | Cyclophosphamide | Dosage and administration | Methotrexate | Stem cells | Central nervous system | Brain | Therapy | Transplants & implants | Systemic diseases | Stem cell transplantation | Nervous system | Transplantation | Cerebrospinal fluid | Confidence intervals | Cytarabine | Historical account | Remission | Busulfan | Autografts | Dexamethasone | Rituximab | Patients | Survival | Lymphoma | Medical prognosis | Lymphomas
Journal Article
World Neurosurgery, ISSN 1878-8750, 08/2019, Volume 128, pp. 18 - 22
Central nervous system (CNS) relapse is an uncommon complication of diffuse large B cell lymphoma and is associated with significant mortality and morbidity.... 
Secondary central nervous system lymphoma | Chemotherapy | Intraventricular lymphoma | PRIMARY CNS LYMPHOMA | SURGERY | INTRAVENOUS METHOTREXATE | DIAGNOSIS | INVOLVEMENT | CLINICAL NEUROLOGY | TRIAL | PROPHYLAXIS | RITUXIMAB | NON-HODGKINS-LYMPHOMA | CENTRAL-NERVOUS-SYSTEM | RECURRENCE | Anthracyclines | Lymphomas | Methotrexate | Health aspects | Vincristine | Mortality
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 5, pp. 654 - 662
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 05/2016, Volume 91, Issue 5, pp. 486 - 491
Central nervous system (CNS) involvement in patients with mature B non‐Hodgkin lymphoma, post‐transplantation proliferative disorder and acute lymphoblastic... 
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER | RECURRENT CNS | ACUTE-LYMPHOBLASTIC-LEUKEMIA | ANTI-CD20 ANTIBODY | HIGH-RISK | NON-HODGKIN-LYMPHOMA | CENTRAL-NERVOUS-SYSTEM | HEMATOLOGY | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | ONCOLOGY GROUP | Peripheral Nervous System Diseases - chemically induced | Postoperative Complications - etiology | Humans | Drug Evaluation | Injections, Intraventricular | Salvage Therapy | Child, Preschool | Infant | Male | Transplantation | Antineoplastic Agents - administration & dosage | Postoperative Complications - mortality | Seizures - chemically induced | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antineoplastic Agents - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Female | Retrospective Studies | Postoperative Complications - drug therapy | Child | Headache - chemically induced | Lymphoproliferative Disorders - etiology | Lymphoma, B-Cell - drug therapy | Rituximab - adverse effects | Drug Hypersensitivity - etiology | Injections, Spinal | Antigens, CD20 - immunology | Lymphoma, B-Cell - mortality | Treatment Outcome | Combined Modality Therapy | Remission Induction | Rituximab - administration & dosage | B-Lymphocytes - drug effects | Lymphoproliferative Disorders - mortality | B-Lymphocytes - immunology | Adolescent | Lymphoproliferative Disorders - drug therapy | Antimitotic agents | Lymphomas | Antineoplastic agents | Leukemia | Index Medicus
Journal Article